{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:57:49Z","timestamp":1781600269678,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00861-w","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:23:23Z","timestamp":1775823803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants"],"prefix":"10.1186","volume":"24","author":[{"given":"Nicola","family":"Altamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Giorgio","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pradella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Cavalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pellicori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierandrea","family":"Vinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Panizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cominotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja","family":"Tera\u017e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"La Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Biolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"3","key":"861_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/17474086.2019.1583555","volume":"12","author":"E Campello","year":"2019","unstructured":"Campello E, Spiezia L, Adamo A, Simioni P. Thrombophilia, risk factors and prevention. Expert Rev Hematol. 2019, Mar;12(3):147\u201358. Epub 2019 Feb 26. PMID: 30773075. https:\/\/doi.org\/10.1080\/17474086.2019.1583555.","journal-title":"Expert Rev Hematol"},{"issue":"11","key":"861_CR2","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1111\/jth.15025","volume":"18","author":"M Gierula","year":"2020","unstructured":"Gierula M, Ahnstr\u00f6m J. Anticoagulant protein S-new insights on interactions and functions. J Thromb Haemost. 2020, Nov;18(11):2801\u201311. Epub 2020 Aug 24. PMID: 32702208. https:\/\/doi.org\/10.1111\/jth.15025.","journal-title":"J Thromb Haemost"},{"key":"861_CR3","doi-asserted-by":"publisher","unstructured":"Pezeshkpoor B, Oldenburg J, Pavlova A. Experiences in routine genetic analysis of hereditary hemorrhagic, thrombotic, and platelet disorders. Hamostaseologie. 2022 Feb 28 Oct;42(S 01):S5\u201312. https:\/\/doi.org\/10.1055\/a-1726-4793.","DOI":"10.1055\/a-1726-4793"},{"issue":"1","key":"861_CR4","doi-asserted-by":"publisher","first-page":"2337907","DOI":"10.1080\/09537104.2024.2337907","volume":"35","author":"FS Alshehri","year":"2024","unstructured":"Alshehri FS, Bashmeil AA, Alamar IA, Alouda SK. The natural anticoagulant protein S; hemostatic functions and deficiency. Platelets. 2024, Dec;35(1):2337907. Epub 2024 Apr 11. PMID: 38602463. https:\/\/doi.org\/10.1080\/09537104.2024.2337907.","journal-title":"Platelets"},{"issue":"4","key":"861_CR5","first-page":"459","volume":"22","author":"E Wypasek","year":"2013","unstructured":"Wypasek E, Undas A. Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med. 2013, Jul-Aug;22(4):459\u201367. PMID: 23986205.","journal-title":"Adv Clin Exp Med"},{"issue":"3","key":"861_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1046\/j.1365-2141.2001.02813.x","volume":"113","author":"AC Dykes","year":"2001","unstructured":"Dykes AC, Walker ID, McMahon AD, Islam SI, Tait RC. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol. 2001, Jun;113(3):636\u201341. PMID: 11380449. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02813.x.","journal-title":"Br J Haematol"},{"issue":"6","key":"861_CR7","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1182\/blood.V64.6.1297.1297","volume":"64","author":"HP Schwarz","year":"1984","unstructured":"Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood. 1984, Dec;64(6):1297\u2013300. PMID: 6238642.","journal-title":"Blood"},{"issue":"6","key":"861_CR8","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1172\/JCI111632","volume":"74","author":"PC Comp","year":"1984","unstructured":"Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J. Clin. Invest. 1984, Dec;74(6):2082\u201388. PMID: 6239877; PMCID: PMC425398. https:\/\/doi.org\/10.1172\/JCI111632.","journal-title":"J. Clin. Invest"},{"issue":"24","key":"861_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJM198412133112401","volume":"311","author":"PC Comp","year":"1984","unstructured":"Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984, Dec, 13;311(24):1525\u201328. PMID: 6239102. https:\/\/doi.org\/10.1056\/NEJM198412133112401.","journal-title":"N Engl J Med"},{"issue":"5","key":"861_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.7326\/0003-4819-106-5-677","volume":"106","author":"L Engesser","year":"1987","unstructured":"Engesser L, Broekmans AW, Bri\u00ebt E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med. 1987, May;106(5):677\u201382. PMID: 2952034. https:\/\/doi.org\/10.7326\/0003-4819-106-5-677.","journal-title":"Ann Intern Med"},{"issue":"1","key":"861_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0038-1657551","volume":"78","author":"D Borgel","year":"1997","unstructured":"Borgel D, Gandrille S, Aiach M. Protein S deficiency. Thromb Haemost. 1997, Jul;78(1):351\u201356. PMID: 9198178.","journal-title":"Thromb Haemost"},{"issue":"12","key":"861_CR12","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMra1700365","volume":"377","author":"JM Connors","year":"2017","unstructured":"Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017, Sep, 21;377(12):1177\u201387. PMID: 28930509. https:\/\/doi.org\/10.1056\/NEJMra1700365.","journal-title":"N Engl J Med"},{"key":"861_CR13","unstructured":"Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: part 2. In: Thromb Haemost. 1996 Dec; 76(6): 824-34. Erratum in: Thromb Haemost 77(5): 1997 May. p. 1047. PMID: 8971998."},{"issue":"3","key":"861_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-2003-44640","volume":"3","author":"B Cosmi","year":"2003","unstructured":"Cosmi B, Palareti G. Oral anticoagulant therapy in venous thromboembolism. Semin Vasc Med. 2003, Aug;3(3):303\u201314. PMID: 15199464. https:\/\/doi.org\/10.1055\/s-2003-44640.","journal-title":"Semin Vasc Med"},{"issue":"1.2","key":"861_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2152\/jmi.66.182","volume":"66","author":"S Yagi","year":"2019","unstructured":"Yagi S, Kagawa K, Fujimoto E, Sata M. Recurrent venous thrombosis during direct oral anticoagulant therapy in a patient with protein S deficiency. J Med Invest. 2019;66(1.2):182\u201384. PMID: 31064935. https:\/\/doi.org\/10.2152\/jmi.66.182.","journal-title":"J Med Invest"},{"issue":"6","key":"861_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/MBC.0000000000000613","volume":"28","author":"A Undas","year":"2017","unstructured":"Undas A, Goralczyk T. Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients. Blood Coagul Fibrinolysis. 2017, Sep;28(6):438\u201342. PMID: 28079536 https:\/\/doi.org\/10.1097\/MBC.0000000000000613.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"861_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MBC.0000000000000929","volume":"31","author":"J Lou","year":"2020","unstructured":"Lou J, Yin L, Ke X, Zhang L, Xu F, Liu Z. A case-report of two patients with hereditary protein S deficiency treated by rivaroxaban. Blood Coagul Fibrinolysis. 2020, Sep;31(6):405\u201309. PMID: 32815916. https:\/\/doi.org\/10.1097\/MBC.0000000000000929.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"13","key":"861_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/JBM.S344083","volume":"3","author":"K Al Sulaiman","year":"2022","unstructured":"Al Sulaiman K, Alsuwayyid F, Alrashidi A, Alhijris M, Almutairi F, Alharthi F, et al. Apixaban use in patients with protein C and S deficiency: a case series and review of literature. J Blood Med. 2022, Mar;3(13):105\u201311. PMID: 35264892; PMCID: PMC8901412. https:\/\/doi.org\/10.2147\/JBM.S344083.","journal-title":"J Blood Med"},{"issue":"1","key":"861_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11239-016-1428-2","volume":"43","author":"JW Skelley","year":"2017","unstructured":"Skelley JW, White CW, Thomason AR. The use of direct oral anticoagulants in inherited thrombophilia. J Thromb Thrombolysis. 2017, Jan;43(1):24\u201330. PMID: 27734187. https:\/\/doi.org\/10.1007\/s11239-016-1428-2.","journal-title":"J Thromb Thrombolysis"},{"key":"861_CR20","doi-asserted-by":"publisher","unstructured":"Serrao A, Lucani B, Mansour D, Ferretti A, Baldacci E, Santoro C, et al. Direct oral anticoagulants in patients affected by major congenital thrombophilia. Mediterr J Hematol Infect Dis. 2019, Jul, 1;11(1):e2019044. PMID: 31308920; PMCID: PMC6613626. https:\/\/doi.org\/10.4084\/MJHID.2019.044.","DOI":"10.4084\/MJHID.2019.044"},{"issue":"2","key":"861_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11239-023-02842-6","volume":"56","author":"S Ligia","year":"2023","unstructured":"Ligia S, Musiu P, Serrao A, Santoro C, Taglietti A, Capriata M, et al. Low-dose apixaban or rivaroxaban as secondary prophylaxis of upper extremity deep vein thrombosis. J Thromb Thrombolysis. 2023, Aug;56(2):323\u201326. Epub 2023 Jun 21. PMID: 37341894. https:\/\/doi.org\/10.1007\/s11239-023-02842-6.","journal-title":"J Thromb Thrombolysis"},{"key":"861_CR22","doi-asserted-by":"publisher","unstructured":"Poli D, Parisi R, Antonucci E, Barcella L, Bucherini E, Chistolini A, et al. Low-dose direct oral anticoagulants for secondary prevention in patients at high risk for recurrence due to history of recurrent venous thromboembolic events or severe thrombophilia: a retrospective analysis of the Italian survey on anTicoagulated pAtients RegisTry 2. J Thromb Haemost. 2025, Aug;11:S1538\u20137836(25)00514\u20138. Epub ahead of print. PMID: 40803569. https:\/\/doi.org\/10.1016\/j.jtha.2025.07.034.","DOI":"10.1016\/j.jtha.2025.07.034"},{"key":"861_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1055\/s-0037-1614334","volume":"82","author":"G Liberti","year":"1999","unstructured":"Liberti G, Bertina RM, Rosendaal FR. Hormonal state rather than age influences Cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency. Thromb. Haemost. 1999;82:1093\u201396.","journal-title":"Thromb. Haemost"},{"key":"861_CR24","first-page":"645","volume":"25","author":"HE Solberg","year":"1987","unstructured":", Solberg HE. Approved recommendation (1987) on the theory of Reference values. Part 5. Statistical treatment of collected Reference values. Determ Reference Limits. J Clin Chem Clin Biochem. 1987;25:645\u201356.","journal-title":"Determ Reference Limits. J Clin Chem Clin Biochem"},{"issue":"1","key":"861_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jth.15109","volume":"19","author":"RA Marlar","year":"2021","unstructured":"Marlar RA, Gausman JN, Tsuda H, Rollins-Raval MA, Brinkman HJM. Recommendations for clinical laboratory testing for protein S deficiency: communication from the SSC committee plasma coagulation inhibitors of the ISTH. J Thromb Haemost. 2021, Jan;19(1):68\u201374. PMID: 33405382. https:\/\/doi.org\/10.1111\/jth.15109.","journal-title":"J Thromb Haemost"},{"key":"861_CR26","doi-asserted-by":"publisher","unstructured":"Bikdeli B, Zahedi Tajrishi F, Sadeghipour P, Talasaz AH, Fanikos J, Lippi G, et al. Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review. JAMA Cardiol. 2022 Jul 1; 7(7): 747-759. doi: 10.1001\/jamacardio.2022.1292.Erratum in:JAMA Cardiol.2022, Jul, 1;(7):776. 7. PMID: 35648414. https:\/\/doi.org\/10.1001\/jamacardio.2022.2240.","DOI":"10.1001\/jamacardio.2022.2240"},{"key":"861_CR27","doi-asserted-by":"publisher","unstructured":"Mai V, Bertoletti L, Cucherat M, Jardel S, Grange C, Provencher S, et al. Extended anticoagulation for the secondary prevention of venous thromboembolic events: an updated network meta-analysis. PLoS One. 2019, Apr, 1;14(4):e0214134. PMID: 30933993; PMCID: PMC6443183. https:\/\/doi.org\/10.1371\/journal.pone.0214134.","DOI":"10.1371\/journal.pone.0214134"},{"issue":"1","key":"861_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1182\/hematology.2019000026","volume":"2019","author":"AT Cohen","year":"2019","unstructured":"Cohen AT, Hunt BJ. Is there a role for low-dose DOACs as prophylaxis? Hematol Am Soc Hematol Educ Program. 2019, Dec, 6;2019(1):187\u201393. PMID: 31808883; PMCID: PMC6913471. https:\/\/doi.org\/10.1182\/hematology.2019000026.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"8","key":"861_CR29","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1055\/a-1450-8178","volume":"121","author":"J Douxfils","year":"2021","unstructured":"Douxfils J, Adcock DM, Bates SM, Favaloro EJ, Gouin-Thibault I, Guillermo C, et al. Update of the International Council for Standardization in Haematology Recommendations for laboratory measurement of direct oral anticoagulants. Thromb Haemost. 2021, Aug;121(8):1008\u201320. Epub 2021 May 30. PMID: 33742436. https:\/\/doi.org\/10.1055\/a-1450-8178.","journal-title":"Thromb Haemost"},{"key":"861_CR30","doi-asserted-by":"publisher","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. External reviewers. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. Oct, 9;23; (10):1676.doi:1612\u201376. 10.1093\/europace\/euab065.Erratum in:Europace. 2021. PMID: 33895845; PMCID: PMC11636576. https:\/\/doi.org\/10.1093\/europace\/euab157.","DOI":"10.1093\/europace\/euab157"},{"key":"861_CR31","doi-asserted-by":"publisher","unstructured":"Mulder R, van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Mulder AB, Middeldorp S, et al. Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: results from a retrospective family cohort study. Thromb Res. 2010, Oct;126(4):e249\u201354. Epub 2010 Aug 11. PMID: 20705334. https:\/\/doi.org\/10.1016\/j.thromres.2010.07.013.","DOI":"10.1016\/j.thromres.2010.07.013"},{"key":"861_CR32","doi-asserted-by":"publisher","unstructured":"Darlow J, Mould H. Thrombophilia testing in the era of direct oral anticoagulants. Clin Med (Lond). 2021, Sep;21(5):e487\u201391. Epub 2021 Sep 7. PMID: 34493545; PMCID: PMC8439516. https:\/\/doi.org\/10.7861\/clinmed.2020-1008.","DOI":"10.7861\/clinmed.2020-1008"},{"key":"861_CR33","doi-asserted-by":"publisher","unstructured":"Margetic S. Diagnostic algorithm for thrombophilia screening. Clin Chem Lab Med. 2010, Dec;48(Suppl, 1):S27\u201339. Epub 2010 Nov 5. PMID: 21054193. https:\/\/doi.org\/10.1515\/CCLM.2010.362.","DOI":"10.1515\/CCLM.2010.362"},{"issue":"8","key":"861_CR34","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/gerona\/glu240","volume":"70","author":"V Siguret","year":"2015","unstructured":"Siguret V, Emmerich J, Belleville T, Golmard JL, Mazoyer E, Gouin-Thibault I, et al. Prevalence of Hereditary thrombophilia in patients older than 75 years with venous thromboembolism referred for thrombophilia screening. J Gerontol Biol Sci Med Sci. 2015, Aug;70(8):977\u201381. Epub 2015 Feb 9. PMID: 25665832. https:\/\/doi.org\/10.1093\/gerona\/glu240.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"21","key":"861_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.46234\/ccdcw2023.090","volume":"5","author":"D Fu","year":"2023","unstructured":"Fu D, Xiao L. The progress of the global Tobacco cessation strategies. China Cdc Wkly. 2023, May, 26;5(21):475\u201378. PMID: 37405265; PMCID: PMC10316592. https:\/\/doi.org\/10.46234\/ccdcw2023.090.","journal-title":"China Cdc Wkly"},{"issue":"11","key":"861_CR36","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMe2510566","volume":"393","author":"NA Rigotti","year":"2025","unstructured":"Rigotti NA, Siddiqi K, Malina D, Pittman G, Taichman DB, Guinn KM, et al. Reducing Tobacco use worldwide - a New perspective series. N Engl J Med. 2025, Sep, 18;393(11):1129\u201330. Epub 2025 Sep 13. PMID: 40948445. https:\/\/doi.org\/10.1056\/NEJMe2510566.","journal-title":"N Engl J Med"},{"key":"861_CR37","doi-asserted-by":"publisher","unstructured":"Asta F, Minardi V, Contoli B, Possenti V, Casigliani V, Masocco M. Did the pandemic change lifestyle behaviours in Italy? An interrupted time series analysis on the four main NCDs behavioural risk factors from 2008 to 2023. BMC Public Health. 2025 Feb 27; 25(1): 799. doi: 10.1186\/s12889-025-22062-2.Erratum in:BMC Public Health.2025 Apr, 7;(1):1308. 25. PMID: 40016716; PMCID: PMC11869655. https:\/\/doi.org\/10.1186\/s12889-025-22147-y.","DOI":"10.1186\/s12889-025-22147-y"},{"key":"861_CR38","doi-asserted-by":"publisher","unstructured":"Tettamanti M, Marcon G. Cohort profile: \u2018centenari a Trieste\u2019 (CaT), a study of the health status of centenarians in a small defined area of Italy. BMJ Open. 2018, Feb, 8;8(2):e019250. PMID: 29439076; PMCID: PMC5829861. https:\/\/doi.org\/10.1136\/bmjopen-2017-019250.","DOI":"10.1136\/bmjopen-2017-019250"},{"key":"861_CR39","doi-asserted-by":"publisher","unstructured":"Johnson NV, Khor B, Van Cott EM. Advances in laboratory testing for thrombophilia. Am J Hematol. 2012, May;87 Suppl, (1):S108\u201312. Epub 2012 Apr 4. PMID: 22473489. https:\/\/doi.org\/10.1002\/ajh.23186.","DOI":"10.1002\/ajh.23186"},{"issue":"1","key":"861_CR40","first-page":"59","volume":"84","author":"B Z\u00f6ller","year":"1999","unstructured":"Z\u00f6ller B, Garc\u00eda de Frutos P, Hillarp A, Dahlb\u00e4ck B. Thrombophilia as a multigenic disease. Haematologica. 1999, Jan;84(1):59\u201370. PMID: 10091393.","journal-title":"Haematologica"},{"issue":"1","key":"861_CR41","first-page":"92","volume":"86","author":"RM Bertina","year":"2001","unstructured":"Bertina RM. Genetic approach to thrombophilia. Thromb Haemost. 2001, Jul;86(1):92\u2013103. PMID: 11487047.","journal-title":"Thromb Haemost"},{"issue":"1","key":"861_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-0038-1657542","volume":"78","author":"U Seligsohn","year":"1997","unstructured":"Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost. 1997, Jul;78(1):297\u2013301. PMID: 9198169.","journal-title":"Thromb Haemost"},{"issue":"6","key":"861_CR43","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1055\/s-0038-1665427","volume":"78","author":"M Makris","year":"1997","unstructured":"Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, et al. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost. 1997, Dec;78(6):1426\u201329. PMID: 9423788.","journal-title":"Thromb Haemost"},{"issue":"3","key":"861_CR44","doi-asserted-by":"publisher","first-page":"102864","DOI":"10.1016\/j.rpth.2025.102864","volume":"9","author":"S Najaf Zadeh","year":"2025","unstructured":"Najaf Zadeh S, Schmidli F, Jalowiec KA, Tritschler T, Xu Y, Haynes A, et al. Prevalence and factors associated with high-risk thrombophilia: a single-center cross-sectional study of 3550 patients at a tertiary thrombosis centre in Switzerland. Res Pract Thromb Haemost. 2025, Apr, 17;9(3):102864. PMID: 40475025; PMCID: PMC12138441. https:\/\/doi.org\/10.1016\/j.rpth.2025.102864.","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"861_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00001721-200006000-00002","volume":"11","author":"G Castaman","year":"2000","unstructured":"Castaman G, Tosetto A, Cappellari A, Ruggeri M, Rodeghiero F. The A20210 allele in the prothrombin gene enhances the risk of venous thrombosis in carriers of inherited protein S deficiency. Blood Coagul Fibrinolysis. 2000, Jun;11(4):321\u201326. PMID: 10847418. https:\/\/doi.org\/10.1097\/00001721-200006000-00002.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"861_CR46","unstructured":"https:\/\/www.aifa.gov.it\/documents\/20142\/2769025\/2025.04.03_Pierluigi-Russo_Rapporto-OsMed_Roma.pdf. Dec 17th 2025."},{"issue":"1","key":"861_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/a-2275-0408","volume":"44","author":"A Tutusaus","year":"2024","unstructured":"Tutusaus A, Morales A, Garc\u00eda de Frutos P, Mar\u00ed M. GAS6\/TAM Axis as therapeutic target in Liver Diseases. Semin Liver Dis. 2024, Feb;44(1):99\u2013114. Epub 2024 Feb 23. PMID: 38395061; PMCID: PMC11027478. https:\/\/doi.org\/10.1055\/a-2275-0408.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"861_CR48","doi-asserted-by":"publisher","first-page":"13741","DOI":"10.1038\/s41598-020-70687-7","volume":"10","author":"JS Katzeff","year":"2020","unstructured":"Katzeff JS, Bright F, Lo K, Kril JJ, Connolly A, Crossett B, et al. Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation. Sci Rep. 2020, Aug, 13;10(1):13741. PMID: 32792518; PMCID: PMC7426269. https:\/\/doi.org\/10.1038\/s41598-020-70687-7.","journal-title":"Sci Rep"},{"issue":"23","key":"861_CR49","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1182\/blood-2010-01-262386","volume":"115","author":"D Zhu","year":"2010","unstructured":"Zhu D, Wang Y, Singh I, Bell RD, Deane R, Zhong Z, et al. Protein S controls hypoxic\/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood. 2010, Jun, 10;115(23):4963\u201372. Epub 2010 Mar 26. PMID: 20348395; PMCID: PMC2890172. https:\/\/doi.org\/10.1182\/blood-2010-01-262386.","journal-title":"Blood"},{"key":"861_CR50","doi-asserted-by":"publisher","unstructured":"Zhong Z, Wang Y, Guo H, Sagare A, Fern\u00e1ndez JA, Bell RD, et al. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region. J Neurosci. 44(15):e0435242024. 2024 Apr 10. PMID: 21084607; PMCID: PMC3012432. https:\/\/doi.org\/10.1523\/JNEUROSCI.0435-24.2024.","DOI":"10.1523\/JNEUROSCI.0435-24.2024"},{"issue":"2","key":"861_CR51","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/stem.1862","volume":"33","author":"A Ginisty","year":"2015","unstructured":"Ginisty A, G\u00e9ly-Pernot A, Abaamrane L, Morel F, Arnault P, Coronas V, et al. Evidence for a subventricular zone neural stem cell phagocytic activity stimulated by the vitamin K-dependent factor protein S. STEM Cells. 2015, Feb;33(2):515\u201325. PMID: 25308179. https:\/\/doi.org\/10.1002\/stem.1862.","journal-title":"STEM Cells"},{"key":"861_CR52","doi-asserted-by":"publisher","unstructured":"Hu Y, Tang Z, Zhu W, Xu S. Clinical reasoning: a teenager with persistent headache. Neurology. 2019, Mar, 26;92(13):e1526\u201331. PMID: 30910948. https:\/\/doi.org\/10.1212\/WNL.0000000000007184.","DOI":"10.1212\/WNL.0000000000007184"},{"issue":"1","key":"861_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/BPL-210125","volume":"7","author":"T Burstyn-Cohen","year":"2021","unstructured":"Burstyn-Cohen T, Hochberg A. TAM signaling in the nervous system. Brain Plast. 2021, Aug, 23;7(1):33\u201346. PMID: 34631419; PMCID: PMC8461745. https:\/\/doi.org\/10.3233\/BPL-210125.","journal-title":"Brain Plast"},{"key":"861_CR54","doi-asserted-by":"publisher","unstructured":"Hoirisch-Clapauch S, Amaral OB, Mezzasalma MA, Panizzutti R, Nardi AE. Dysfunction in the coagulation system and schizophrenia. Transl Psychiatry. 2016, Jan, 5;6(1):e704. PMID: 26731441; PMCID: PMC5068878. https:\/\/doi.org\/10.1038\/tp.2015.204.","DOI":"10.1038\/tp.2015.204"},{"issue":"3","key":"861_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ijlh.12623","volume":"39","author":"Hern\u00e1ndez Zamora","year":"2017","unstructured":"Hern\u00e1ndez Zamora, Gonz\u00e1lez-Espinosa, Zavala-Hern\u00e1ndez, Rosales-Cruz E, Reyes-Maldonado E. Coagulation factors, anticoagulant proteins, and plasminogen in Mexican older adults. Int J Lab Hematol. 2017, Jun;39(3):293\u2013300. Epub 2017 Mar 6. PMID: 28263027. https:\/\/doi.org\/10.1111\/ijlh.12623.","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"861_CR56","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1055\/s-0038-1650638","volume":"76","author":"DA Lane","year":"1996","unstructured":"Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: part 1. Thromb Haemost. 1996, Nov;76(5):651\u201362. PMID: 8950768.","journal-title":"Thromb Haemost"},{"issue":"3","key":"861_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1532\/IJH97.A20514","volume":"83","author":"T Miyata","year":"2006","unstructured":"Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol. 2006, Apr;83(3):217\u201323. PMID: 16720551. https:\/\/doi.org\/10.1532\/IJH97.A20514.","journal-title":"Int J Hematol"},{"key":"861_CR58","unstructured":"https:\/\/genome.ucsc.edu\/cgi-in\/hgTracks?db=hg38%26lastVirtModeType=default%26lastVirtModeExtraState=%26virtModeType=default%26virtMode=0%26nonVirtPosition=%26position=chr3%3A93873051%2D93973896%26hgsid=3244243975_9LAgNhXub98yxfnsEPJfyYC6ZwZ4. Oct 14th 2025."},{"key":"861_CR59","unstructured":"https:\/\/www.proteinatlas.org\/ENSG00000184500-PROS1\/tissue. Oct 14th 2025."},{"issue":"19","key":"861_CR60","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","volume":"170","author":"A Iorio","year":"2010","unstructured":"Iorio A, Kearon C, Filippucci E, Marcucci M, Macura A, Pengo V, et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med. 2010, Oct, 25;170(19):1710\u201316. PMID: 20975016. https:\/\/doi.org\/10.1001\/archinternmed.2010.367.","journal-title":"Arch Intern Med"},{"key":"861_CR61","doi-asserted-by":"publisher","unstructured":"Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020, Aug;5(370):m2177. PMID: 32759284. https:\/\/doi.org\/10.1136\/bmj.m2177.","DOI":"10.1136\/bmj.m2177"},{"key":"861_CR62","doi-asserted-by":"publisher","unstructured":"Piazza G, Bikdeli B, Pandey AK, Krishnathasan D, Khairani CD, Bejjani A, et al. HI-PRO trial investigators. Apixaban for Extended treatment of provoked venous thromboembolism. N Engl J Med. 2025, Aug, 30. Epub ahead of print. PMID: 40888734. https:\/\/doi.org\/10.1056\/NEJMoa2509426.","DOI":"10.1056\/NEJMoa2509426"},{"issue":"5","key":"861_CR63","first-page":"375","volume":"3","author":"B Cosmi","year":"2004","unstructured":"Cosmi B, Palareti G. Extended treatment for venous thromboembolism: how long is long enough? Curr Hematol Rep. 2004, Sep;3(5):375\u201381. PMID: 15341706.","journal-title":"Curr Hematol Rep"},{"issue":"3","key":"861_CR64","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/ATVBAHA.108.182428","volume":"29","author":"T Zhu","year":"2009","unstructured":"Zhu T, Martinez I, Emmerich J. Venous thromboembolism: risk factors for recurrence. Arterioscler Thromb Vasc Biol. 2009, Mar;29(3):298\u2013310. PMID: 19228602. https:\/\/doi.org\/10.1161\/ATVBAHA.108.182428.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"861_CR65","first-page":"603","volume":"98","author":"G Palareti","year":"2007","unstructured":"Palareti G. Attuali metodologie per la determinazione della durata del trattamento anticoagulante [Current criteria to determine the duration of anticoagulant therapy]. Recenti Prog Med. 2007, Dec;98(12):603\u201306. Italian. PMID: 18369033.","journal-title":"Recenti Prog Med"},{"key":"861_CR66","doi-asserted-by":"publisher","unstructured":"Akhtar M, Nabi R, Saadia S, Ashraf DA, Hassan SM, Akhtar M, et al. Reduced-dose versus full-dose direct oral anticoagulants in the Extended treatment of venous thromboembolism: a systematic review and meta-analysis. Cardiovasc Drugs Ther. 2025, Aug, 22. Epub ahead of print. PMID: 40844745. https:\/\/doi.org\/10.1007\/s10557-025-07759-1.","DOI":"10.1007\/s10557-025-07759-1"},{"issue":"254","key":"861_CR67","doi-asserted-by":"publisher","first-page":"109476","DOI":"10.1016\/j.thromres.2025.109476","volume":"11","author":"A Ibrahim","year":"2025","unstructured":"Ibrahim A, Shalabi L, Zreigh S, Tawfik AM, Hamed BM, Elsawy M, et al. Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: a meta-analysis with trial sequential analysis and reconstructed time-to-event data. Thromb Res. 2025, Sep;11(254):109476. Epub ahead of print. PMID: 40957133. https:\/\/doi.org\/10.1016\/j.thromres.2025.109476.","journal-title":"Thromb Res"},{"issue":"6","key":"861_CR68","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","volume":"157","author":"PV Jenkins","year":"2012","unstructured":"Jenkins PV, Rawley O, Smith OP, O\u2019Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012, Jun;157(6):653\u201363. Epub 2012 Apr 25. PMID: 22530883. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09134.x.","journal-title":"Br J Haematol"},{"key":"861_CR69","doi-asserted-by":"publisher","unstructured":"Finsterer J. Hereditary protein S deficiency and activated protein C Resistance manifesting with recurrent thrombosis and stroke. Cureus. 2023, Jan, 20;15(1):e34012. PMID: 36824536; PMCID: PMC9941041. https:\/\/doi.org\/10.7759\/cureus.34012.","DOI":"10.7759\/cureus.34012"},{"issue":"6","key":"861_CR70","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/MBC.0b013e328201ca8a","volume":"18","author":"A Tripodi","year":"2007","unstructured":"Tripodi A, Asti D, Chantarangkul V, Biguzzi E, Mannucci PM. Interference of factor V Leiden on protein S activity: evaluation of a new prothrombin time-based assay. Blood Coagul Fibrinolysis. 2007, Sep;18(6):543\u201346. PMID: 17762529. https:\/\/doi.org\/10.1097\/MBC.0b013e328201ca8a.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"861_CR71","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1172\/JCI113836","volume":"82","author":"CA Mitchell","year":"1988","unstructured":"Mitchell CA, Jane SM, Salem HH. Inhibition of the anticoagulant activity of protein S by prothrombin. J Clin Invest. 1988, Dec;82(6):2142\u201347. PMID: 2974048; PMCID: PMC442798. https:\/\/doi.org\/10.1172\/JCI113836.","journal-title":"J. Clin. Invest"},{"issue":"5","key":"861_CR72","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1182\/blood-2003-02-0620","volume":"102","author":"RR Koenen","year":"2003","unstructured":"Koenen RR, Tans G, van Oerle R, Hamuly\u00e1k K, Rosing J, Hackeng TM. The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation. Blood. 2003, Sep, 1;102(5):1686\u201392. Epub 2003 May 1. PMID: 12730108. https:\/\/doi.org\/10.1182\/blood-2003-02-0620.","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1186\/s12959-026-00884-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000}}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00861-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:43:42Z","timestamp":1781599422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00861-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00861-w","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12959-026-00884-3","URL":"https:\/\/doi.org\/10.1186\/s12959-026-00884-3","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Each of the patients involved in the study signed written informed consents. A template of the two forms is enclosed in \u201cSupplementary Material\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Each of the patients involved in the study signed written informed consents. A template of the two forms is enclosed in \u201cSupplementary Material\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}